Guillain-Barré Syndrome Not Likely Related to SARS-CoV-2 Infection

In an ongoing prospective international study, no increase in cases of GBS was observed during the first wave of the SARS-CoV-2 pandemic.

To explore whether SARS-CoV-2 infection is associated with Guillain-Barré syndrome (GBS) and to identify any distinct characteristics, researchers reviewed all patients included in the International GBS Outcome Study (IGOS) between January 30 and May 30, 2020. The IGOS is an international, multicenter, prospective observational cohort study begun in 2012. Patients were classified as having “possible” SARS-CoV-2 infection if they had one clinical sign of infection, “probable” infection if radiographic findings suggested infection or clinical signs and epidemiological link both were present, or “confirmed” infection if they had confirmatory laboratory results.

During the study period, 49 patients with GBS were included in the IGOS: 21 with no …

Reviewing Author

John C. Probasco, MD

Disclosures

Grant/Research Support Genetech/Roche

Editorial BoardsThe Neurohospitalist

Leadership Positions in Professional SocietiesNeurohospitalist Society (President; Chair, Research Subcommittee)

John C. Probasco, MD

Disclosures

Grant/Research Support Genetech/Roche

Editorial BoardsThe Neurohospitalist

Leadership Positions in Professional SocietiesNeurohospitalist Society (President; Chair, Research Subcommittee)

Guillain-Barré Syndrome Not Likely Related to SARS-CoV-2 Infection

Topics

Reviewing Author